<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In search for a potent dilatator or deactivator of constriction of cerebrovascular smooth muscle, the effects of a specific <z:chebi fb="68" ids="48706">antagonist</z:chebi> of the calcium influx necessary for the excitation-contraction coupling process was studied on isolated human pial arteries </plain></SENT>
<SENT sid="1" pm="."><plain>The arteries were constricted by addition of <z:chebi fb="15" ids="33569">noradrenaline</z:chebi>, 5-hydroxytryptamine, human plasma or blood </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> these agents induced a strong contraction which could effectively be reduced by addition of the <z:chebi fb="1" ids="39099">Ca+</z:chebi>+-<z:chebi fb="68" ids="48706">antagonist</z:chebi>, <z:chebi fb="1" ids="7565">nifedipine</z:chebi>, to the organ bath </plain></SENT>
<SENT sid="3" pm="."><plain>It is suggested that calcium <z:chebi fb="68" ids="48706">antagonists</z:chebi> might be of value in the treatment of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebrovascular spasm</z:e> following a <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> </plain></SENT>
</text></document>